This potent lipid mediator is an agonist of five S1P receptors (S1P1–5), which regulate cell fate and appear to be a valuable therapeutic target in PD and other neurodegenerative diseases [14,15]. The gene discussed is S1PR1; the disease is Parkinson disease.